Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Early tolerability and safety of fingolimod in clinical practice.
Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.
A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity.
The Immune Pathogenesis of Multiple Sclerosis.
Tackling autoimmunity with gene therapy.
Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality.
Human pluripotent stem cell-derived neural constructs for predicting neural toxicity.
Analysis of miRNA in Normal Appearing White Matter to Identify Altered CNS Pathways in Multiple Sclerosis.
Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?
Melatonin Redox Activity. Its Potential Clinical Application in Neurodegenerative Disorders.
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis.
Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.
Future directions of multiple sclerosis rehabilitation research.
Upper limb motor rehabilitation impacts white matter microstructure in multiple sclerosis.
A changing treatment landscape for multiple sclerosis: challenges and opportunities.
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.
Induction of cognitive fatigue in MS patients through cognitive and physical load.
Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study.
A qualitative review of the neurophysiological underpinnings of fatigue in multiple sclerosis.
Flow Cytometric Assay Detecting Cytotoxicity against Human Endogenous Retrovirus Antigens Expressed on Cultured Multiple Sclerosis Cells.
Dimethyl fumarate : a Janus-faced substance?
Simultaneous Pml-Iris After Discontinuation of Natalizumab in A Patient With MS.
Soluble CD146 in cerebrospinal fluid of active multiple sclerosis.
Cytomegalovirus and multiple sclerosis risk.
Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: A randomised controlled feasibility study.

Pages